Menu
Back to User profile » Dr Zhifan Zeng
Papers published by Dr Zhifan Zeng:
Nomogram to Predict Distant Metastasis Probability for Pathological Complete Response Rectal Cancer Patients After Neoadjuvant Chemoradiotherapy [Corrigendum]
Jiang T, Liu S, Wu X, Liu X, Li W, Yang S, Cai P, Xi S, Zeng Z, Gao Y, Chen G, Xiao W
Cancer Management and Research 2022, 14:2533-2534
Published Date: 25 August 2022
Nomogram to Predict Distant Metastasis Probability for Pathological Complete Response Rectal Cancer Patients After Neoadjuvant Chemoradiotherapy
Jiang T, Liu S, Wu X, Liu X, Li W, Yang S, Cai P, Xi S, Zeng Z, Gao Y, Chen G, Xiao W
Cancer Management and Research 2021, 13:4751-4761
Published Date: 15 June 2021
Serum Apolipoprotein A-I Predicts Response of Rectal Cancer to Neoadjuvant Chemoradiotherapy
Guo S, Chen C, Zeng Z, Wang Q, Jiang W, Gao Y, Chang H
Cancer Management and Research 2021, 13:2623-2631
Published Date: 18 March 2021
ypTNM category combined with AJCC tumor regression grade for screening patients with the worst prognosis after neoadjuvant chemoradiation therapy for locally advanced rectal cancer
Wei JW, Huang R, Guo SP, Zhang XH, Xi SY, Wang QX, Chang H, Wang XH, Xiao WW, Zeng ZF, Gao YH
Cancer Management and Research 2018, 10:5219-5225
Published Date: 31 October 2018
The high pCR rate of sandwich neoadjuvant treatment in locally advanced rectal cancer may translate into a better long-term survival benefit: 5-year outcome of a Phase II clinical trial
Hu YH, Wei JW, Chang H, Xiao WW, Lin JZ, Cai MY, Cai PQ, Kong LH, Chen G, Pan ZZ, Zeng ZF, Ding PR, Gao YH
Cancer Management and Research 2018, 10:4363-4369
Published Date: 10 October 2018
Lymphocyte-to-monocyte ratio before chemoradiotherapy represents a prognostic predictor for locally advanced rectal cancer
Deng YX, Lin JZ, Peng JH, Zhao YJ, Sui QQ, Wu XJ, Lu ZH, Gao YH, Zeng ZF, Pan ZZ
OncoTargets and Therapy 2017, 10:5575-5583
Published Date: 22 November 2017